COMPREHENSIVE
BUSINESS PLAN
Strategic Roadmap & Financial Model for Investor Growth & Market Expansion
Key Metrics & Strategic Value
BovRes delivers quantifiable business value across three critical dimensions: market protection, operational efficiency, and scalable revenue generation.
R150B Market Protected
South Africa's annual livestock exports and domestic agricultural output secured against FMD crisis disruption. Every herd equipped with BR-1 protects premium market access.
48h Pre-Symptomatic Detection
Earliest biological detection available via wearable technology. Closes the 48-hour intervention window before herd-wide FMD exposure. Zero false positives through individual baseline mapping.
Scalable Revenue Model
4-layer monetization: 75% hardware margins + recurring SaaS + consumables + VaaS licensing. Year 3 target of R145M revenue with 50%+ EBITDA margins from software scaling.
The Problem: A Billion-Rand Crisis
Foot and Mouth Disease is endemic across 77% of the world's livestock territory. A single confirmed outbreak in South Africa triggers automatic international export bans, costing the industry billions in lost trade revenue.
The Culling Crisis
FMD affects cattle, sheep, goats, pigs, and over 70 cloven-hoofed species. It spreads with exceptional speed—airborne transmission up to 60km under favorable wind conditions. By the time a farmer observes symptoms, full herd exposure is complete.
- —R5M–R10M in livestock value destroyed per outbreak
- —Production drop of 25–50% during recovery
- —Irreplaceable genetic lineages eliminated via culling
- —3–6 months of farm operational disruption
Export & Trade Consequences
South Africa exports R15B+ in animal products annually. The country maintains FMD-free zones in the Western Cape and parts of KwaZulu-Natal—enabling premium export access to EU and UK markets. A single outbreak triggers regional industry shutdown.
- —Automatic international export ban on confirmation
- —Loss of FMD-free status requires 3–12 months to restore
- —Regional industry shutdown beyond infected farm
- —Premium market premiums lost indefinitely
Why Current Solutions Fail
The livestock industry currently relies on three inadequate responses to FMD:
- — Reactive Culling: The most common response. Destroys wealth, genetic lineages, and does nothing to prevent re-infection. A cure as destructive as the disease.
- — Vaccination: Provides partial protection but disqualifies vaccinated animals from export certification under OIE protocols. The vaccine trap forces farmers to choose between herd protection and trade access.
- — Manual Observation: Farmers observe animals 1–2 times daily. Symptoms appear 3–5 days post-infection. By observation, full herd exposure is already complete.
The Innovation: BR-1 BovResonator
BR-1 is the world's first wearable device combining ultraweak biophoton sensing, AI gait analysis, and scalar-wave intervention technology. A Digital Immune System for livestock—powered by SHEA technology.
Ultraweak Biophoton Sensing
PMT sensors detect cellular oxidative stress 48 hours before visible FMD symptoms. Measures biophoton coherence loss—the earliest known biological marker of viral infection detectable via wearable.
Scalar-Wave Intervention (SHEA)
Phase-inverse scalar waves create destructive interference with the FMD virus frequency signature at the cellular level. Non-chemical, non-invasive, DIVA-compliant intervention via graphene Caduceus antenna.
AI Health Intelligence
n8n-orchestrated AI layer maps individual animal circadian rhythms. Gait analysis detects weight-shifting asymmetry unique to early hoof lesion formation. Zero manual intervention required.
Market Opportunity: A R150B Addressable Market
BovRes operates at the intersection of three high-growth markets: precision livestock farming, agricultural biosecurity, and FMD-endemic region trade protection. The opportunity is both large and urgent.
R150B
South African Market Size
Annual livestock exports and domestic agricultural value at risk from FMD disruption. Every herd equipped with BR-1 protects premium market access.
77%
Export Risk Exposure
Global livestock population in FMD-endemic zones. Single outbreak triggers automatic international export bans costing billions in lost trade revenue.
$30B+
Global TAM
Precision livestock farming market growing at 12–15% CAGR. BR-1 captures disease-detection and intervention segment across all FMD-endemic regions.
0
Direct Competitors
BR-1 is the only wearable combining pre-symptomatic FMD detection with non-chemical scalar intervention in a DIVA-compliant package. No competitor exists.
Why Now? Three Convergent Advantages
Three distinct market forces converge in 2026—creating the optimal window for BovRes to establish market leadership and capture early adopter share before competition emerges.
Local Manufacturing Capability
South Africa has established supply chains for graphene (SabiNano), PCB fabrication, and precision electronics manufacturing. 80–90% local sourcing possible at scale. Cost advantage of R650 BOM vs global competitors.
Market Position: First-mover advantage in SADC region with local, cost-competitive manufacturing.
Data Intelligence (Herd-Link)
Herd-Link SaaS platform aggregates biophoton data from deployed collars. 18+ months of calibration data in Year 2 trains proprietary SHEA algorithm models. Competitors cannot replicate without equivalent dataset.
Market Position: Data moat that grows stronger as deployed fleet expands. VaaS licensing opportunity in Year 3.
Competitive Positioning
Global livestock monitoring incumbents (CowManager, SCR, Moocall) operate in symptom-detection space. BR-1 owns the pre-symptomatic, non-chemical intervention market. No head-to-head competition until Year 3+.
Market Position: 18–24 month window to establish category dominance before deep-pocketed incumbents enter.
Business Model & Revenue Streams
BovRes generates revenue across three compounding layers — hardware, recurring SaaS, and integration licensing — each reinforcing the next and improving overall margin as scale increases.
Unit Economics
The BR-1 BOM ranges from R1,400 at pilot scale down to R650 at full production, driven by component volume discounts and local supply chain optimisation. At a target selling price of R1,500/unit, early batches operate near break-even — building field validation data — while scale transforms hardware into a high-margin business.
Recurring Revenue: 1os.io Platform
Cloud Dashboard, Analytics & Herd Intelligence
Monthly SaaS subscription: R299–R899/month per farm, tiered by herd size and feature set — real-time biophoton monitoring, AI health alerts, veterinary integration, breeding recommendations, export compliance reporting, and market price indexing.
Running on Burmain Technologies-owned infrastructure with zero foreign cloud dependency, the platform is POPIA-compliant and eligible for DALRRD and government tenders.
Projected Adoption: 40% of hardware customers convert to SaaS by Year 2; 65% by Year 3 = R8.2M annual recurring revenue by 2028 at 85% gross margin.
3-Year Revenue Projections
Conservative growth model based on tier-1 dairy adoption rates, cooperative penetration, and SaaS conversion curves aligned with AgriTech benchmarks.
CASH FLOW ASSUMPTIONS
- • Average hardware ASP: R6,100 (conservative mix of tiers)
- • SaaS CAC payback: 18 months; 8-year LTV assumed
- • Working capital: 60-day inventory, 45-day receivables
- • COGS includes: BOM (60%), manufacturing (13%), logistics (5%), warranty reserves (2%)
Use of Funds Breakdown
Strategic allocation of R50M capital raise across product development, manufacturing capacity, go-to-market, and working capital to accelerate market adoption.
Planned Deployment
| Product Development | R17.5M (35%) |
| R&D, cloud platform, mobile app, firmware updates, regulatory compliance | |
| Manufacturing & Supply Chain | R15M (30%) |
| Production tooling, inventory buildup, logistics, supplier partnerships | |
| Go-to-Market | R10M (20%) |
| Sales team, cooperative partnerships, marketing, field training, demo units | |
| Working Capital | R7.5M (15%) |
| Operating runway, payroll, contingency reserves |
Allocation by Timeline
Year 1 (2026): 60% deployment
Focus on platform completion, production tooling, and pilot market validation. R30M spend on hardware R&D, manufacturing setup, and early sales team.
Year 2 (2027): 30% deployment
Scale manufacturing, expand cooperative partnerships, SaaS launch acceleration. R15M deployment as revenue offsets operational costs.
Year 3 (2028): 10% deployment + Profitability
Remaining capital for international expansion and strategic acquisitions. Business reaches cash flow positive at Q4 2028.
Go-to-Market Strategy & Traction
Two-tier distribution strategy targeting Tier 1 commercial dairies and Tier 2 provincial veterinary services to establish beachhead and expand systematically.
TIER 1: Dairy Cooperatives
Target Profile
- Size: 500–5,000 head herd
- Location: KwaZulu-Natal, Eastern Cape, Free State
- Economics: 60–90% produce for export; export-grade requirements
- Motivation: Cost reduction, compliance automation, traceability
- Volume: 8,000–10,000 units target by 2028
Partnership model: Cooperative bulk purchasing discounts (15–20% off retail), integrated invoicing, dedicated support channels.
TIER 2: Veterinary Networks
Target Profile
- Type: Provincial vet clinics, mixed-practice farms
- Scale: 50–300 head client herds
- Drivers: Herd health optimization, treatment tracking, remote monitoring
- Revenue Model: Referral fees (10% per sale); co-branded SaaS
- Volume: 2,000–3,000 units via vet channel by 2028
Partnership model: Training on integrated diagnostics, API access to herd records, performance incentives for referrals.
Critical Milestones
Q1 2026
Pilot Launch
Hardware design finalized; 50 units deployed to 5 pilot farms (KZN); SaaS MVP released; strategic partnerships signed with 2 Tier 1 cooperatives.
Q2–Q3 2026
Commercial Rollout
Production ramp to 300 units/month; sales team expanded to 6; first cooperative bulk order (500 units); SaaS conversion: 40 paying subscribers.
Q4 2026
Market Validation
Cumulative 800 units sold; 3 major cooperatives active; revenue R250K; SaaS: 100+ subscribers. Year-end: Series A close confirmed.
Q1–Q2 2027
Scaling Phase
Production: 800 units/month; Tier 2 vet network onboarding (15 partner clinics); SaaS: 400 subscribers; revenue run-rate R4.5M/quarter.
Q3–Q4 2027
Expansion
International: Namibia & Botswana trials; 6 new cooperatives; veterinary API integrations with 8 regional practices; cumulative R18.5M revenue YoY.
Q1–Q2 2028
Market Leadership
Production: 1,200 units/month; 12,000 cumulative units deployed; SaaS: 5,000+ subscribers; Series B fundraising underway.
Q3–Q4 2028
Profitability & Regional Dominance
Cumulative revenue: R145M; EBITDA positive; 6,500 SaaS subscribers; 15+ regional partnerships active; Path to IPO or strategic exit confirmed.
Success Metrics: Monthly Active Users (SaaS), hardware sales velocity, cooperative conversion rate (target: 35% of Tier 1 cooperatives by Q4 2027), veterinary partner NPS (target: 65+), revenue per unit economics, and SaaS net retention rate (target: 115%+).
Team & Expertise
Cross-disciplinary leadership spanning hardware engineering, quantum physics, regulatory compliance, and veterinary science.
Strategic Partnerships
Collaboration with industry leaders in materials science, cloud infrastructure, livestock cooperatives, and global health organizations.
SabiNano
Graphene material supply and nanostructure integration for sensor enhancement and scalable manufacturing.
Burmain Technologies
Owns the server hardware, n8n workflow server, and 1os.io platform — SA-hosted infrastructure with zero foreign cloud dependency.
Grasslands Agriculture
Regional cooperative providing pilot site access and market validation for BR-1 field deployment.
M&C Winders
Wearable device manufacturing and production scaling for commercial deployment phase.
Mantech Electronics
Electronic component supply chain and PCB manufacturing for sensor platform standardization.
WOAH
World Organization for Animal Health—global disease surveillance and protocol alignment.
IBM Watson
AI and machine learning infrastructure for advanced predictive analytics and pattern recognition.
Stellenbosch University
Research partnerships in animal health, biosensing, and veterinary epidemiology.
SAVMA
South African Veterinary Medical Association—professional credentialing and veterinary adoption pathways.
Industry & Subject Matter Experts
Advisory board members bring deep expertise in veterinary medicine, regulatory strategy, and agricultural technology commercialization.
Veterinary Expertise
- — FMD Epidemiology: Disease transmission modeling and outbreak prediction protocols.
- — Biosensing & Wearables: Implementation of non-invasive biometric monitoring in livestock.
- — Trade & Export Certification: OIE protocols and international market access requirements.
Regulatory & Commercial Strategy
- — Medical Device Regulation: FDA, EMA, and SADC certification pathways for wearable sensors.
- — AgTech Go-to-Market: Farmer adoption strategies and cooperative distribution models.
- — IP & Patent Strategy: Global patent filing and competitive moat protection.
Ready to Invest in BovRes?
Join the founding investors backing the world's first pre-symptomatic FMD detection and intervention platform.
Your details are protected. A draft investment agreement will be emailed to you for review — no funds are transferred until both parties countersign.
Submit Your Investment Pledge
Select your equity tier and submit your pledge. You'll receive a pre-filled investment agreement for review and countersignature.